NICE Recommends Cost Effectiveness Of Pfizer’s Smoking Cessation Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Varenicline is superior to nicotine replacement therapy and bupropion in achieving continuous abstinence, NICE determines.
You may also be interested in...
Pfizer Approvals Don’t Quit: Chantix Clears FDA For Smoking Cessation
Advantage of varenicline over GSK’s Zyban is more pronounced over the short-term than long-term.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.